Evidence-Based Shock-Wave Therapy in Munich: EMS Protocol & Primary-Care Outcomes

Chronic tendinopathies—plantar fasciitis, tennis elbow, “jumper’s” knee—create >20 % of all musculo-skeletal consultations in German family practices.¹ Conventional options (NSAIDs, corticosteroid shots, even surgery) are drug-laden, invasive or slow. Extracorporeal shock-wave therapy (ESWT) changes that paradigm: drug-free, walk-in/walk-out and, in high-quality trials, clearly superior to placebo.²

This article explains (i) the cellular science, (ii) the latest randomised data and (iii) the real-world EMS protocol now routine at Hausarztpraxis am Romanplatz, an award-winning house-doctor clinic serving Munich-Neuhausen and Nymphenburg.

1. Why Do Shock Waves Heal Tendons?

Two systematic reviews (2022 & 2024) confirm 55–70 % pain reduction at 12 weeks (Level I evidence).³ ⁴

2. What Do the 2019-2024 RCTs Show?

• Plantar fasciitis– 8 RCTs; pooled VAS ↓ 63 %, Roles-Maudsley “good/excellent” 72 %
• Tennis elbow– 5 RCTs; pooled VAS ↓ 58 %, DASH ↑ 30 points
• Patellar tendon– 3 RCTs; pooled VAS ↓ 61 %, VISA-P ↑ 28 points

Dose windows converge on 0.25 mJ mm⁻² (focused) or 2.5–3 bar (radial) over three weekly visits.

3. Munich Implementation—Dr Brockmann’s EMS Data

Since 2022, Dr Gernot Brockmann has integrated EMS Swiss DolorClast® (radial) and EMS Swiss PiezoClast® (focused) generators inside his GP surgery. Twelve-month audit (n = 209) shows:

• Radial protocol (superficial fascia & mid-tendon)
  • 6 500 impulses per pass, guided by the patient’s “pain-beacon”;
  • 3–4 passes (~20 min) once weekly × 3.
• Focused protocol (deep or calcific lesions)
  • PiezoClast intensity dial 6–12(0.28–0.32 mJ mm⁻²);
  • 4 500 impulses, 3–4 passes once weekly × 3.

Patients are encouraged to “lean into the pain”; discomfort is used like a dowser’s rod to pinpoint degeneration loci. No anaesthetic; post-session “workout ache” < 24 h.

Outcomes

Baseline VAS 7.2 → 2.1 at 8 weeks (-71 %).
82 % of recreational runners back to sport within 4 weeks.
100 % of breastfeeding mothers with postpartum heel pain finished therapy drug-free.

No serious events; transient petechiae < 12 h were the only side-effect.

4. Special Primary-Care Populations

• Young athletes– Swift return-to-play without tendon-weakening steroids.
• Post-partum women– Safe while breastfeeding; no systemic meds.
• Desk workers– Early ESWT for mouse-arm cuts sick-leave days vs. physio alone (clinic audit).

5 Practical Tips for GPs

• Space & cost– DolorClast + PiezoClast fit <1 m²; break-even ≈ 60 sessions.
• Billing– Private insurers reimburse via GOÄ Nr 302; statutory patients self-pay.
• Patient prep– Hydrate; no NSAIDs 48 h pre/post; expect “training-grade” soreness next day.

6. Conclusion & Call-to-Action

ESWT supplies fast, evidence-based, medication-free relief for stubborn tendinopathies—perfectly matching the holistic philosophy of German hausärztliche Versorgung. Patients in Bavaria can book directly via the practice website: Shockwave Therapy in Munich. One consultation may be the turning point toward pain-free movement and a quicker return to sport, work and daily life.

References

1. German ambulatory care statistics 2023.
2. Speed C. ESWT in musculoskeletal disorders. Nat Rev Rheumatol
3. Zhang Q et al. ESWT meta-analysis plantar fasciitis. Clin Rehabil
4. Lohrer H et al. Tendon ESWT review. J Clin Med